Cargando…
Two Dabigatran Fast Reversals in a 4-month Period – a Case Report
INTRODUCTION: Idarucizumab is available for immediate reversal of dabigatran-induced anticoagulation in life-threatening bleeding or urgent surgery in patients with non-valvular atrial fibrillation (nvAF). CASE DESCRIPTION: We report a case of an 85-year-old female treated with dabigatran for nvAF,...
Autores principales: | Fagundes, Vítor, Mesquita, Mari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936929/ https://www.ncbi.nlm.nih.gov/pubmed/31893202 http://dx.doi.org/10.12890/2019_001311 |
Ejemplares similares
-
Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report
por: Kafke, Waldemar, et al.
Publicado: (2016) -
Thrombocytopenia induced by dabigatran: two case reports
por: Kang, Hyun Goo, et al.
Publicado: (2017) -
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
por: Giannandrea, David, et al.
Publicado: (2019) -
Idarucizumab: A novel antidote for reversal of dabigatran
por: Rehman, Abdul, et al.
Publicado: (2016) -
Use of Idarucizumab for dabigatran reversal: Emergency department experience in two cases with subdural haematoma
por: Edwards, Gail, et al.
Publicado: (2017)